Rare Disease, Big Impact with Matt Wilsey
Podcast |
Bio Eats World
Publisher |
Andreessen Horowitz
Media Type |
audio
Categories Via RSS |
Life Sciences
Science
Technology
Publication Date |
Dec 10, 2024
Episode Duration |
00:23:08

In this episode, Matt Wilsey joins Jorge Conde to share the profound personal story of his daughter Grace's diagnosis with NGLY1 deficiency and how it catalyzed his journey to founding a biotech startup, Grace Science, aimed at developing a cure for his daughter’s condition.

Matt emphasizes the importance of strategic partnerships, like his collaboration with Nobel laureate Carolyn Bertozzi, and sheds light on the search for gene therapies for rare diseases. 

Check out our previous episode with Carolyn Bertozzi here.

Matt Wilsey, cofounder and CEO of Grace Science, joins Jorge Conde, general partner of a16z Bio + Health.

In this episode, Matt Wilsey joins Jorge Conde to share the profound personal story of his daughter Grace's diagnosis with NGLY1 deficiency and how it catalyzed his journey to founding a biotech startup, Grace Science, aimed at developing a cure for his daughter’s condition.

Matt emphasizes the importance of strategic partnerships, like his collaboration with Nobel laureate Carolyn Bertozzi, and sheds light on the search for gene therapies for rare diseases. 

Check out our previous episode with Carolyn Bertozzi here.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review